ALDX logo

Aldeyra Therapeutics (ALDX)

Profile

Full Name

Aldeyra Therapeutics, Inc.

Ticker Symbol

ALDX

Exchange

NASDAQ

Country

United States

IPO

May 2, 2014

Indexes

Not included

Employees

9

Key Details

Price

$2.12(+10.99%)

Market cap

$126.58M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$0.94(-46.88% YoY)

PE ratio

-

Next earnings date

May 2, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price Performance

Price Range

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Shares Outstanding

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

EPS

Profit

Expenses

EBIT & EBITDA

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Liabilities

Debt

Equity & Capital

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

CAPEX

Free Cash Flow

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

ROA & ROE

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Analyst ratings

Recent major analysts updates

Apr 7, 25 BTIG
Buy
Apr 4, 25 HC Wainwright & Co.
Buy
Mar 3, 25 HC Wainwright & Co.
Buy
Aug 9, 24 HC Wainwright & Co.
Buy
Aug 2, 24 HC Wainwright & Co.
Buy
May 6, 24 Oppenheimer
Outperform
May 6, 24 HC Wainwright & Co.
Buy
Apr 3, 24 Oppenheimer
Outperform
Oct 17, 23 Oppenheimer
Perform
Oct 17, 23 Citigroup
Buy

Institutional Ownership

  • What is the ticker symbol for Aldeyra Therapeutics?
  • Does Aldeyra Therapeutics pay dividends?
  • What sector is Aldeyra Therapeutics in?
  • What industry is Aldeyra Therapeutics in?
  • What country is Aldeyra Therapeutics based in?
  • When did Aldeyra Therapeutics go public?
  • Is Aldeyra Therapeutics in the S&P 500?
  • Is Aldeyra Therapeutics in the NASDAQ 100?
  • Is Aldeyra Therapeutics in the Dow Jones?
  • When was Aldeyra Therapeutics's last earnings report?
  • When does Aldeyra Therapeutics report earnings?
  • Should I buy Aldeyra Therapeutics stock now?

What is the ticker symbol for Aldeyra Therapeutics?

The ticker symbol for Aldeyra Therapeutics is NASDAQ:ALDX

Does Aldeyra Therapeutics pay dividends?

No, Aldeyra Therapeutics does not pay dividends

What sector is Aldeyra Therapeutics in?

Aldeyra Therapeutics is in the Healthcare sector

What industry is Aldeyra Therapeutics in?

Aldeyra Therapeutics is in the Biotechnology industry

What country is Aldeyra Therapeutics based in?

Aldeyra Therapeutics is headquartered in United States

When did Aldeyra Therapeutics go public?

Aldeyra Therapeutics's initial public offering (IPO) was on May 2, 2014

Is Aldeyra Therapeutics in the S&P 500?

No, Aldeyra Therapeutics is not included in the S&P 500 index

Is Aldeyra Therapeutics in the NASDAQ 100?

No, Aldeyra Therapeutics is not included in the NASDAQ 100 index

Is Aldeyra Therapeutics in the Dow Jones?

No, Aldeyra Therapeutics is not included in the Dow Jones index

When was Aldeyra Therapeutics's last earnings report?

Aldeyra Therapeutics's most recent earnings report was on Nov 7, 2024

When does Aldeyra Therapeutics report earnings?

The next expected earnings date for Aldeyra Therapeutics is May 2, 2025

Should I buy Aldeyra Therapeutics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page